相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of eradication therapy in Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: A meta-analysis
Kyoungwon Jung et al.
HELICOBACTER (2021)
Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy
Hidehiko Takigawa et al.
GASTRIC CANCER (2021)
Thyroid MALT lymphoma: self-harm to gain potential T-cell help
Fangtian Wu et al.
LEUKEMIA (2021)
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Zucca et al.
ANNALS OF ONCOLOGY (2020)
Depth of Remission Following First-Line Treatment Is an Independent Prognostic Marker for Progression-Free Survival in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
Barbara Kiesewetter et al.
CANCERS (2020)
Immunomodulatory treatment for mucosa-associated lymphoid tissue lymphoma (MALTlymphoma)
Barbara Kiesewetter et al.
HEMATOLOGICAL ONCOLOGY (2020)
PCR analysis and specific immunohistochemistry revealing a high prevalence of non-Helicobacter pyloriHelicobacters inHelicobacter pylori-negative gastric disease patients in Japan: High susceptibility to an Hp eradication regimen
Masahiko Nakamura et al.
HELICOBACTER (2020)
Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing
Carole Pissot Soldermann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses
Luciano Cascione et al.
HAEMATOLOGICA (2019)
Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites
Sarah Moody et al.
HAEMATOLOGICA (2018)
Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality
Francesco Cucco et al.
LABORATORY INVESTIGATION (2018)
Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement
Jiyeon Hyeon et al.
MODERN PATHOLOGY (2018)
Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites
Sarah Moody et al.
HAEMATOLOGICA (2018)
Clarithromycin as a repurposing drug against MALT lymphoma
Andres J. M. Ferreri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
Sung-Hsin Kuo et al.
SCIENTIFIC REPORTS (2017)
Drug discovery and therapeutic delivery for the treatment of B and T cell tumors
Regan Stephenson et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Clinicopathologic Characteristics and Treatment of Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)
Markus Raderer et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
2016 US Lymphoid Malignancy Statistics by World Health Organization Subtypes
Lauren R. Teras et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
MALT lymphoma: A paradigm of NF-κB dysregulation
Ming-Qing Du
SEMINARS IN CANCER BIOLOGY (2016)
Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up
Markus Raderer et al.
ANNALS OF HEMATOLOGY (2015)
Long-Term Outcomes and Patterns of Relapse of Early-Stage Extranodal Marginal Zone Lymphoma Treated With Radiation Therapy With Curative Intent
Sewit Teckie et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review
Naoki Asano et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Molecular Pathogenesis of MALT Lymphoma
Katharina Troppan et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)
Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study
A. Amiot et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice
Christiane Copie-Bergman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Molecular Pathways: Targeting MALT1 Paracaspase Activity in Lymphoma
Lorena Fontan et al.
CLINICAL CANCER RESEARCH (2013)
Eradication Therapy in Helicobacter pylori-negative, Gastric Low-grade Mucosa–associated Lymphoid Tissue Lymphoma Patients
Angelo Zullo et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
Lorena Fontan et al.
CANCER CELL (2012)
Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan
Shotaro Nakamura et al.
GUT (2012)
Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)
A. Conconi et al.
ANNALS OF ONCOLOGY (2011)
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
A. Ruskone -Fourmestraux et al.
GUT (2011)
Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-κB Activation
Shaun Rosebeck et al.
SCIENCE (2011)
Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development
Xavier Sagaert et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
A phase II study of bortezomib in patients with MALT lymphoma
Marlene Troch et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
MALT lymphoma in patients with autoimmune diseases:: a comparative analysis of characteristics and clinical course
S. Woehrer et al.
LEUKEMIA (2007)
Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma - A clinicopathologic and molecular study with reference to antibiotic treatment
Shotaro Nakamura et al.
CANCER (2006)
Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas
M Raderer et al.
GUT (2006)
Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication
T Wündisch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy
M Lévy et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites:: significant association with CagA strains of H pylori in gastric MALT lymphoma
HT Ye et al.
BLOOD (2003)
High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma
HT Ye et al.
BLOOD (2003)
分享论文
